Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter U Ardelt

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Urology|March 12, 2016
Author ReplyPeter U Ardelt, Felix Burkhalter
Journal of Pediatric Urology|November 28, 2016
The SIGHT questionnaire: A novel assessment tool for Satisfaction In Genital Hypospadias TreatmentPeter U Ardelt, Marco Cederqvist, Michael Barth, et al.
Urologia Internationalis|February 9, 2013
The glandular resection and central embedding modification (GRACE) in Duckett and Barcat hypospadias repairPeter U Ardelt, Marco Cederquist, Martin Schoenthaler, et al.
BJU International|June 8, 2011
The efferent segment in continent cutaneous urinary diversion: a comprehensive review of the literaturePeter U Ardelt, Christopher R J Woodhouse, Hubertus Riedmiller, et al.
Journal of Pediatric Surgery|May 19, 2012
Glandular resection and central embedding in hypospadias repair--a novel modification of the Barcat techniquePeter U Ardelt, Tobias Glaser, Martin Schoenthaler, et al.
Chemistry & Biology|August 25, 2004
Design and validation of a bifunctional ligand display system for receptor targetingLimor Chen, Amado J Zurita, Peter U Ardelt, et al.
Plos One|March 6, 2015
An anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladderPeter U Ardelt, Jan Ebbing, Fabian Adams, et al.
Urology|December 18, 2015
Urothelial Cancer in Renal Transplant Recipients: Incidence, Risk Factors, and Oncological OutcomePeter U Ardelt, Malte Rieken, Jan Ebbing, et al.
The Journal of Urology|March 12, 2003
Targeting urothelium: ex vivo assay standardization and selection of internalizing ligandsPeter U Ardelt, Christopher G Wood, Limor Chen, et al.
Cancer|December 4, 2009
Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladderPeter U Ardelt, Burkhard Kneitz, Patrick Adam, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Urology|March 12, 2016
Author ReplyPeter U Ardelt, Felix Burkhalter
Journal of Pediatric Urology|November 28, 2016
The SIGHT questionnaire: A novel assessment tool for Satisfaction In Genital Hypospadias TreatmentPeter U Ardelt, Marco Cederqvist, Michael Barth, et al.
Urologia Internationalis|February 9, 2013
The glandular resection and central embedding modification (GRACE) in Duckett and Barcat hypospadias repairPeter U Ardelt, Marco Cederquist, Martin Schoenthaler, et al.
BJU International|June 8, 2011
The efferent segment in continent cutaneous urinary diversion: a comprehensive review of the literaturePeter U Ardelt, Christopher R J Woodhouse, Hubertus Riedmiller, et al.
Journal of Pediatric Surgery|May 19, 2012
Glandular resection and central embedding in hypospadias repair--a novel modification of the Barcat techniquePeter U Ardelt, Tobias Glaser, Martin Schoenthaler, et al.
Chemistry & Biology|August 25, 2004
Design and validation of a bifunctional ligand display system for receptor targetingLimor Chen, Amado J Zurita, Peter U Ardelt, et al.
Plos One|March 6, 2015
An anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladderPeter U Ardelt, Jan Ebbing, Fabian Adams, et al.
Urology|December 18, 2015
Urothelial Cancer in Renal Transplant Recipients: Incidence, Risk Factors, and Oncological OutcomePeter U Ardelt, Malte Rieken, Jan Ebbing, et al.
The Journal of Urology|March 12, 2003
Targeting urothelium: ex vivo assay standardization and selection of internalizing ligandsPeter U Ardelt, Christopher G Wood, Limor Chen, et al.
Cancer|December 4, 2009
Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladderPeter U Ardelt, Burkhard Kneitz, Patrick Adam, et al.
Pageof 2